Sentiss Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SENTISS PHARMA, and what generic and branded alternatives to SENTISS PHARMA drugs are available?
SENTISS PHARMA has one approved drug.
Summary for Sentiss Pharma
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Sentiss Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sentiss Pharma | TIMOLOL MALEATE | timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 217195-001 | May 8, 2023 | AT3 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
